LoneStar Heart

LoneStar Heart, Inc. is a biomedical company focused on developing innovative therapies for patients with advanced heart failure. Founded in 2010 and based in Laguna Hills, California, the company is dedicated to preserving and restoring heart function through a range of device and drug-based programs. Key products in development include Algisyl LVR, a self-gelling biopolymer designed to be implanted in the heart to prevent or reverse heart failure progression, and small molecule drugs targeting heart failure treatment. Additionally, LoneStar Heart is exploring cell reprogramming techniques to regenerate cardiac muscle cells. The company collaborates with notable institutions such as the University of Texas Southwestern Medical Center and the Texas Heart Institute, leveraging a combination of mechanical and biomolecular technologies to create effective therapies that enhance the structure and function of the heart.